(2020). Ocrelizumab: SARS-CoV-2 pneumonia: 2 case reports. Reactions Weekly.
Chicago Style Citation"Ocrelizumab: SARS-CoV-2 Pneumonia: 2 Case Reports." Reactions Weekly 2020.
Cita MLA"Ocrelizumab: SARS-CoV-2 Pneumonia: 2 Case Reports." Reactions Weekly 2020.
Atenció: Aquestes cites poden no estar 100% correctes.